CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Tianyu Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Tianyu Pharmaceutical Co Ltd
Jiangkou Chemical Development Zone
Huangyan
Phone: +86 57689189669p:+86 57689189669 TAIZHOU, ZHJ  318020  China Ticker: 300702300702
Business Summary
Zhejiang Tianyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production, and sales of intermediates, active pharmaceutical ingredients (APIs), and formulations. The Company is mainly engaged in the generic APIs and intermediates business, Contract Development and Manufacturing Organization (CDMO) APIs and intermediates business, and formulations business. The Company's products include antihypertensive, antiasthmatic, antidiabetic, lipid-lowering, and anticoagulant drugs. The Company's products and solutions are mainly applied in the treatment of hypertension, asthma, diabetes, hyperlipidemia, and coagulation disorders. The Company mainly operates in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, General Manager YongjunTu 62 11/18/2025 5/28/2011
Chief Financial Officer XiujuanWang 38 4/19/2021 4/19/2021
Deputy General Manager, Secretary of the Board YanWang 43 4/19/2021 4/19/2021
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4,532 (As of 12/31/2024)
Outstanding Shares: 347,977,159 (As of 9/30/2025)
Shareholders: 14,982
Stock Exchange: SHE
Fax Number: +86 57689189660


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 7, 2026